Navigation Links
Sequi-Gen GT and PowerPac 3000 Power Supply, 38 x 50 cm, 220-240 V from Bio-Rad

ProductsSequi-Gen GT and PowerPac 3000 Power Supply, 38 x 50 cm, 220-240 V from Bio-Rad
Company Bio-Rad
Item Sequi-Gen GT and PowerPac 3000 Power Supply, 38 x 50 cm, 220-240 V
Price 
Description The Sequi-Gen GT and PowerPac 3000 system, 220-240 V, is used for nucleic acid separation using a 38 x 50 cm vertical slab gel format. The system includes the modular Sequi-Gen GT electrophoresis cell, which is capable of separating nucleic acids with single base-pair resolution and includes an integral plate chamber (IPC) assembly (IPC and bonded inner glass plate, outer glass plate, and clamp set), GT universal base, GT safety covers with cables, stabilizer bar, precision caster assembly (precision caster base, gasket, tubing, luer tapers, tubing, and syringe), 0.40 mm vinyl sharkstooth comb and spacers, gel temperature indicator, leveling bubble, drain port connector, and instructions. This system also includes a PowerPac 3000 power supply, temperature probe, and instructions.
Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Sequi-Gen GT and PowerPac 3000 Power Supply, 38 x 30 cm, 220-240 V from Bio-Rad
2. PowerPac HV Power Supply With Temperature Probe from Bio-Rad
3. Wide Mini ReadySub-Cell GT Cell and PowerPac Basic Power Supply from Bio-Rad
4. Sub-Cell Model 192 and PowerPac Basic Power Supply from Bio-Rad
5. Mini ReadySub-Cell GT Cell and PowerPac Basic Power Supply from Bio-Rad
6. PowerPac 3000 Power Supply 100/120 V from Bio-Rad
7. Sub-Cell Model 96 and PowerPac Basic Power Supply from Bio-Rad
8. Mini-Sub Cell GT Cell and PowerPac Basic Power Supply from Bio-Rad
9. Mini Trans-Blot and PowerPac Basic Power Supply from Bio-Rad
10. PowerPlant DNA Isolation Kit from Mo Bio Laboratories, Inc.
11. Total Antioxidant Power Colorimetric Assay Kit from Neogen Corporation
Agarose, Type C from Calbiochem
Assay Diluent from BD Biosciences Pharmingen
Chicken Anti-Human Quinolinate phosphoribosyltransferase Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
ICC Diluent Buffer from BD Biosciences Pharmingen
Biology Products:
(Date:11/24/2009)... been prescribed by traditional healers in Brazil ...omach pain to fever and flu. , Now for the first ...n able to scientifically prove the pain relieving ... Brazilian mint. , Testing this ancient South Ame...ciela Rocha was able to show that when prepared as...
(Date:11/24/2009)...remarkable class of ring-shaped protein motors has...erkeley National Laboratory (Berkeley Lab) using a... at the Advanced Light Source (ALS). These protein...replication, and are vital to the survival of all ...ch as the human papillomavirus, which has been lin...
(Date:11/24/2009)...2009) New research on bacterial communities throu...edictable temporal patterns, suggesting that scien...onitoring climate change in the polar regions. The... the National Academy of Sciences Early Edition, ... shifted synchronously over time, correlating with...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 1New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 2New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 3New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 4New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 5New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 6Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 1Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 2Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 3Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 4Cord Blood Registry Maintains Solid Growth in First Quarter 2009 48560 1Cord Blood Registry Maintains Solid Growth in First Quarter 2009 48560 2Cord Blood Registry Maintains Solid Growth in First Quarter 2009 48560 3
... in no small part, on something akin to the square...eplicate in monkey cells, so researchers use a mon...on of simian immunodeficiency virus -- to test pot...apies and vaccines that are effective on SIV don,t...ing a combination of genetic engineering and force...
... is spelled out in our DNA and activated through o... a variety of methods that our cells have evolved .... , Among other things, epigenetics is crucial to... from another, and thus is at the heart of the mys...type of epigenetic change that causes one copy of ...
...(TB) has been linked to HIV/AIDS in a study conduc...chool of Medicine. , Published in the October 26 i...ive-year collaboration between a Yale and South Af... and TB care and treatment. , TB is the most co...infection in sub-Saharan Africa. HIV greatly incre...
Other Biology News:HIV gets a makeover 2Inheritance outside DNA 2HIV/AIDS linked to extensively drug resistant TB 2
(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCa...calcompanyfocusedondevelopingandcommercializingnov...yDiTonno,PresidentandChiefExecutiveOfficer,issched...Conference,tobeheldDecember1-2,2009atTheNewYorkPal...henGhiglieri,ChiefFinancialOfficer,willbeavailable...
(Date:11/24/2009)..., The FBI recently approv...aboratories participating in or generating DNA rec... Madison, WI USA (PRWEB) -- The FB... HS System for use by laboratories participating ...A Index System (NDIS). NDIS currently contains mor...
(Date:11/24/2009)...,, DUBLIN,November24/PRNewswire-FirstCall/--...tybiopharmaceuticalcompany,today,announcedthatitha...glucerasealfa,thecompany,senzymereplacementtherapy....Thisisthethirdmarketing,applicationforvelaglucera...sintheUnitedStatesandCanada. , Basedonaglobal...
(Date:11/24/2009)...,, BOZEN,Italy,November24/PRNewswire/--Healt...njointventurewithagroupofselected,investors.Thisre...e,nameHealthRoboticsCanada,Inc.andwillmarket,insta...ncept,whichincludesthe,revolutionaryproductofferin...oboticsCanadaInc.willalsoprovideassistanceonan"asn...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2